Advertisement
Journal Home
Search for

Volume 30, Issue 2, Pages 83-86 (February 2010)


View previous. 7 of 49 View next.

Overview of What We Know About the Pathophysiology of Laminitis

Susan C. Eades, DVM, PhD, Diplomate ACVIM-LA

Article Outline

Inflammation

Evidence of Cellular Infiltration

Enzymatic Dysregulation

Other Inflammatory Mediators

Oxidants

Metabolic Syndrome

Alteration of Endothelial and Venous Function

References

Copyright

Laminitis is frustrating for veterinarians because current knowledge and understanding of the pathophysiology and progression of the disease are incomplete, limiting efforts to prevent and treat this devastating disease successfully. However, scientific investigations have recently occurred at a phenomenal rate shedding light on the pathophysiologic events involved with laminitis. Development of acute laminitis often follows other primary diseases; therefore, the mechanisms involved in the pathogenesis of laminitis are most likely numerous and interrelated. On the basis of the discussion from the 2007 Havemeyer Meeting,1 inflammation, metabolic disease, and endothelial and vascular dysfunction are considered pivotal events in the development of laminitis.

Inflammation 

return to Article Outline

Evidence of Cellular Infiltration 

Systemic sequelae to inflammation (systemic inflammatory response syndrome) commonly plague equine patients undergoing treatment for numerous conditions, including pleuropneumonia, colitis, enteritis, peritonitis, endometritis, and hepatitis. Although end-organ damage from the systemic inflammatory response can include damage to numerous body tissues, there is no complication more common and devastating during equine inflammatory disease than acute laminitis. Although researchers once questioned whether the disease should be called “laminar degeneration” due to the minimal neutrophilic infiltration present histologically, application of more sensitive research tools has produced abundant evidence of inflammatory changes during laminitis. In laminitis, neutrophils become aggregated to platelets in the early prodromal stage and at the onset of lameness.2, 3 Carbohydrate overload laminitis (corn starch) was prevented in eight ponies by pretreatment with an antagonist of platelet aggregation (platelet fibrinogen receptor antagonist peptide).4 Using immunoperoxidase and CD13 monoclonal antibodies, Black et al documented emigration of neutrophils to perivascular tissues of both the skin and laminae during prodromal stages (3–4 hours) and at onset of lameness after administration of black walnut hardwood extract (BWHE).5 Neutrophil emigration from the circulation is accompanied by reduction in numbers of circulating neutrophils and monocytes.6 Neutrophil and/or monocyte activation in skin, plasma, and lamina 3 and 12 hours after BWHE administration confirm the activation of peripheral white blood cells (WBCs) and the initiation of the systemic inflammatory response syndrome.7 These activated neutrophils produce increased quantities of reactive oxygen species.6 Investigators sought to determine whether these emigrated neutrophils could be the source of matrix metalloproteinases (MMPs) that damage the laminar extracellular matrix. It was determined that neutrophil activation and emigration (as measured by CD 13 immunohistochemical staining of tissues obtained from horses euthanized at 3–4 hours after administration of BWHE and at onset of Obel grade I laminitis) occurred concurrent with peaks in MMP-9 activity (measured by gelatin zymography and polymerase chain reaction [PCR]).8 Evidence of the systemic inflammatory response syndrome was confirmed in horses with BWHE-induced laminitis by documentation of neutrophil infiltration (CD13 immunohistochemistry) in liver and lung within 3 hours after BWE administration.9 In addition, laminar immunohistochemical staining of calprotectin, a marker of remote tissue inflammation and damage during the systemic inflammatory response syndrome in people, is increased at 12 hours after onset of black walnut-induced laminitis in horses.10 This immunohistochemical staining of calprotectin was perivascular, near the epithelial basement membrane, and mostly associated with neutrophil emigration. Furthermore, calprotectin signaling of epithelial damage occurred 12 hours after administration of BWHE, which is 9 hours after the initial onset of neutrophil emigration, suggesting that WBCs emigration is a primary event that is not initiated by epithelial damage. In human keratinocyte preparations, inflammatory cytokines induce production of calprotectin, and calprotectin causes further induction of cytokines. Calprotectin can induce cellular apoptosis, a documented event in equine laminitis.11 Taken together, these results confirm that WBC activation is a significant and early event in acute laminitis, and that these WBCs may be a significant source of damage to the extracellular matrix and epithelium.

Enzymatic Dysregulation 

Although these studies document that WBC activation occurs more rapidly, there is substantial evidence that accelerated enzymatic remodeling with degradation of laminin and type IV and type VII collagen is an important event during laminitis with documented increased in MMP-2 and MMP-9.12, 13, 14, 15, 16 Most recently, real-time PCR documented increased tissue expression of MMP-14 concurrent with decreased amounts of tissue inhibitor of metalloproteinases (TIMPs) in horses with laminitis induced by use of fructan administration.17 In contrast MMP-14 content of the basilar epithelial cells near the basement membrane was depleted based on immunohistochemistry.17 Examination of laminar samples (gelatin zymography for MMP-9 and MMP-2 and myeloperoxidase enzyme-linked immunosorbent assay and real-time PCR for proMMP-2 processing genes) from horses with naturally occurring laminitis, and those administered starch gruel revealed that MMP-9 concentrations correlate directly with activation of neutrophils, suggesting production or induction by inflammatory leukocytes. In contrast, MMP-2 regulation occurred independent of myeloperoxidase concentration, suggesting that dysregulation of MMP-2 occurs independent of inflammatory processes.18 A recent study also examined the expression of genes coding for proteins containing a Disintegrin and Metalloproteinase domain (ADAM), as well as genes encoding the natural inhibitors of these enzymes (TIMP) in horses with carbohydrate overload, BWHE, and naturally occurring laminitis.19, 20 ADAMTS-4 gene expression was strongly upregulated in nearly all horses with experimentally induced and naturally acquired laminitis. The expression of MMP-9 and ADAMTS-5 was also increased in many of the laminitic horses. Furthermore, TIMP-2 gene expression was decreased in most laminitic horses. It appears that improper regulation of the extracellular matrix is an important event in horses with laminitis, whether as part of or independent of the general inflammatory processes.

Other Inflammatory Mediators 

It was determined fairly early in the history of laminitis research that expression of interleukin (IL)-1 and IL-6 increased in laminar tissue of horses with laminitis induced with BWHE extract.21, 22 More recent studies of BWHE and oligofructan models of laminitis have documented increased lamellar mRNA expression of cytokines important in the innate immune response present at the developmental stage of the BWHE model, and at the onset of acute lameness in both the BWHE model and OF model.23 Cytokines characteristic of the adaptive immune response were present at the onset of lameness in the BWHE model.23

Pivotal to our understanding of the systemic inflammatory response syndrome during equine laminitis is the recent discovery of increased expression of pulmonary and hepatic inflammatory mediators in horses administered BWHE. The pattern of proinflammatory cytokine expression in the lung and liver in the BWE model was similar to that reported in other sepsis models, with increases in expression of tumor necrosis factor-α, IL-6, IL-8, and IL-1β within 1.5 hours after administration of BWHE. However, the increases in IL-1β, IL-6, and IL-8 in the lung and liver were all much smaller in magnitude than those occurring in the laminae at the same time points in the BWHE model.23, 24 The reason for the heightened laminar inflammatory response is not known. Unlike what has been shown in human sepsis models, the expression of anti-inflammatory cytokines IL-10 and IL-4 did not increase after BWHE administration.

In addition to this intense lamellar cytokine response, there is evidence for a diverse laminar inflammatory reaction. Noschka et al used an equine-specific cDNA microarray to screen gene expression in laminar tissues collected at 1.5, 3, and 12 hours after BWHE administration.25 As early as 1.5 hours after BWHE administration, genes associated with leukocyte activation and emigration were upregulated. Other genes involved in inflammatory processes, antioxidant processes, and antimicrobial processes were upregulated from tissues collected at the onset of Obel grade I laminitis. Immunohistochemical analysis has revealed that cyclooxygenase-2 is markedly increased in the basal epithelial cells during the first few hours after BWHE administration coincident with leukopenia.26

Oxidants 

Oxidant injury plays an important role in the end-organ insult resulting from the systemic inflammatory response syndrome. Loftus et al evaluated laminar tissues for presence of xanthine oxidase (XO)–dependent production of superoxide anion after administration of BWHE.24 Tissues from liver, lungs, and skin of control and BWHE-treated horses contained superoxide dismutase (SOD). Laminar samples from both groups of horses were devoid of SOD. Tissues from liver, lung, skin, and laminae of control and BWHE-treated horses all had endogenous XO and catalase. The levels of XO and catalase were similar in extracts of laminae from control and BWHE-treated horses. The absence of increased XO activity suggests against the involvement of this reactive oxygen intermediate-generating system in the development of laminar pathology in BWE-treated horses. However, the absence of SOD suggests that the equine digital laminae are highly susceptible to damage by superoxide anion.24

Yin et al evaluated 4-hydroxy-2-nonenal (4-HNE), a lipid aldehyde that forms due to lipid peroxidation occurring during episodes of oxidant stress that can be used as an index of tissue oxidant stress in laminar, lung, liver, and intestinal tissues of horses undergoing BWHE laminitis.27 The laminar concentrations of 49-HNE increased significantly in horses with laminitis; however, they remained normal in lung, liver, and intestinal tract. It is possible that antioxidant systems prevent lipid peroxidation in these other tissues, while damage occurs in the unprotected intestinal tract.

Metabolic Syndrome 

return to Article Outline

Endocrinopathic laminitis is a term that has been used to describe laminitis that occurs in horses with obesity, insulin resistance, pituitary dysfunction, and glucocorticoid administration. Insulin resistance is a common factor in the disease in a large number of these horses. A pivotal discovery that has advanced our understanding of the pathogenesis of laminitis in these horses revealed that intravenous infusion of insulin through a euglycemic hyperinsulinemic clamp technique for 72 hours induced Obel grade 2 laminitis with a mean serum insulin concentration at 1036 μU/mL compared with 14.6 μU/mL in control horses. These results confirm that insulin toxicity is a key factor in triggering laminitis. Serum insulin and leptin concentrations had reproducible accuracy for prediction of laminitis in pastured ponies.28 Furthermore, serum insulin concentrations were significantly higher in ponies that recurrently develop laminitis on pasture than those that do not.29 Mediators of inflammation and oxidant damage may induce lamellar injury increasing the risk for laminitis in obese or insulin-resistant ponies. Treiber et al evaluated markers of inflammation and redox status in pastured ponies with a history of laminitis and determined that there were no differences between markers of antioxidant function and oxidant pressure between ponies with laminitis and those without laminitis.30 However, laminitic ponies had higher serum concentrations of tumor necrosis factor than ponies that were not laminitic.

Alteration of Endothelial and Venous Function 

return to Article Outline

Many of the vascular events during equine laminitis were recently summarized by Robertson et al.31 Laminar edema due to venous constriction was among the earliest vascular events identified in the early stages of BWHE and carbohydrate-induced laminitis.32, 33 This increased venous resistance is concurrent with increased concentrations of endothelin-1 and can be prevented by administration of an antagonist of endothelin-1.3, 34 Endothelin-1 causes intense vasoconstriction of laminar veins, an effect that is enhanced fourfold by L-ng-Nitroargine methyl ester (L-NAME).35 Weiss et al demonstrated platelet activation and platelet-neutrophil activation.4 Localized platelet activation causes vasoconstriction through release of thromboxane and serotonin, which cause laminar vein constriction more than laminar arteriolar constriction. Furthermore, vasoactive amines are formed by bacteria in the gastrointestinal tract and may enter the circulation contributing to the pathogenesis of laminitis.36 Insulin resistance alters endothelial function, which can create a proinflammatory condition leading to platelet and leukocyte activation, increased endothelin production, and production of mediators of inflammation and oxidant stress.37 The earliest laminar events in BWHE-induced laminitis include activation of endothelial adhesion molecules and leukocyte emigration.24

Altered concentrations of vasoactive substances may not have an important effect on regional blood flow, but likely signal alteration in endothelial function.3 The end result of altered endothelial function during laminitis may be creation of a proinflammatory state with increased oxidant stress rather than oxygen deprivation.

The preponderance of these results supports roles for inflammation, endocrinopathic laminitis, and endothelial and venous dysfunction. Inflammation, oxidant stress, and matrix degradation may be factors common to each of these mechanisms that lead to lamellar damage in this devastating disease.

References 

return to Article Outline

1. 1In:  Belknap JK,  Moore JN editor. Special Issue: Inflammatory aspects of equine laminitis. Vet Immunol Immunopath. 129:2009;p. 149–262.

2. 2Weiss DJ, Evanson OA, McClenahan D, Fagliari JJ, Jenkins K. Evaluation of platelet activation and platelet-neutrophil aggregates in ponies with alimentary laminitis. Am J Vet Res. 1997;58:1376–1380. MEDLINE

3. 3Eades SC, Stokes AM, Johnson PJ, LeBlanc CJ, Ganjam VK, Buff PR, et al. Serial alterations in digital hemodynamics and endothelin-1 immunoreactivity, platelet-neutrophil aggregation, and concentrations of nitric oxide, insulin, and glucose in blood obtained from horses following carbohydrate overload. Am J Vet Res. 2007;68:87–94. MEDLINE | CrossRef

4. 4Weiss DJ, Evanson OA, McClenahan D, Fagliari JJ, Dunnwiddie CT, Wells RE. Effect of a competitive inhibitor of platelet aggregation on experimentally induced laminitis in ponies. Am J Vet Res. 1998;59:814–817. MEDLINE

5. 5Black SJ, Lunn DP, Yin C, Hwang M, Lenz SD, Belknap JK. Leukocyte emigration in the early stages of laminitis. Vet Immunol Immunopath. 2006;109:161–166.

6. 6Hurley DJ, Parks RJ, Reber AJ, Donovan DC, Okinaga T, Vandenplas ML, et al. Dynamic changes in circulating leukocytes during the induction of equine laminitis with black walnut extract. Vet Immunol Immunopath. 2006;110:195–206.

7. 7Riggs LM, Franck T, Moore JN, Krunkosky TM, Hurley DJ, Peroni JF, et al. Neutrophil myeloperoxidase measurements in plasma, laminar tissue, and skin of horses given black walnut extract. Am J Vet Res. 2007;68:81–86. MEDLINE | CrossRef

8. 8Loftus JP, Belknap JK, Black SJ. Matrix metalloproteinase-9 in laminae of black walnut extract treated horses correlates with neutrophil abundance. Vet Immunol Immunopath. 2006;113:267–276.

9. 9Stewart AJ, Pettigrew A, Cochran AM, Belknap JK. Indices of inflammation in the lung and liver in the early stages of the black walnut extract model of equine laminitis. Vet Immunol Immunopath. 2009;129:254–260.

10. 10Faleiros RR, Nuovo GJ, Belknap JK. Calprotectin in myeloid and epithelial cells of laminae from horses with black walnut extract-induced laminitis. J Vet Intern Med. 2009;23:174–181. CrossRef

11. 11Faleiros RR, Stokes AM, Eades SC, Kim DY, Paulsen DB, Moore RM. Assessment of apoptosis in epidermal lamellar cells in clinically normal horses and those with laminitis. Am J Vet Res. 2004;65:578–585. MEDLINE | CrossRef

12. 12Pollitt CC, Daradka M. Equine laminitis basement membrane pathology: loss of type IV collagen, type VII collagen and laminin immunostaining. Equine Vet J Suppl. 1998;26:139–144.

13. 13Pollitt CC. Equine laminitis: a revised pathophysiology. Proc Am Assoc Equine Pract. 1999;45:188–192.

14. 14Mungall BA, Pollitt CC. Zymographic analysis of equine laminitis. Histochem Cell Biol. 1999;112:467–472. MEDLINE

15. 15Johnson PJ, Kreeger JM, Keeler M, Ganjam VK, Messer NT. Serum markers of lamellar basement membrane degradation and lamellar histopathological changes in horses affected with laminitis. Equine Vet J. 2000;32:462–468. MEDLINE | CrossRef

16. 16Kyaw-Tanner M, Pollitt CC. Equine laminitis: increased transcription of matrix metalloproteinase-2 (MMP-2) occurs during the developmental phase. Equine Vet J. 2004;36:221–225. MEDLINE | CrossRef

17. 17Kyaw-Tanner MT, Wattle O, van Eps AW, Pollitt CC. Equine laminitis: membrane type matrix metalloproteinase-1 (MMP-14) is involved in acute phase onset. Equine Vet J. 2008;40:482–487. CrossRef

18. 18Loftus JP, Johnson PJ, Belknap JK, Pettigrew A, Black SJ. Leukocyte-derived and endogenous matrix metalloproteinases in the lamellae of horses with naturally acquired and experimentally induced laminitis. Vet Immunol Immunopath. 2009;129:221–230.

19. 19Coyne MJ, Cousin H, Loftus JP, Johnson PJ, Belknap JK, Gradil CM, et al. Cloning and expression of ADAM-related metalloproteases in equine laminitis. Vet Immunol Immunopath. 2009;129:231–241.

20. 20Budak M, Orsini JA, Pollitt C, Rubinstein N. Gene expression in the lamellar dermis-epidermis during the developmental phase of carbohydrate overload-induced laminitis in the horse. Vet Immunol and Immunopath. 2009;131:86–96.

21. 21Fontaine GL, Belknap JK, Allen D, Moore JN, Kroll DL. Expression of interleukin-1beta in the digital laminae of horses in the prodromal stage of experimentally induced laminitis. Am J Vet Res. 2001;62:714–720. MEDLINE | CrossRef

22. 22Waguespack RW, Kemppainen RJ, Cochran A, Lin HC, Belknap JK. Increased expression of MAIL, a cytokine-associated nuclear protein, in the prodromal stage of black walnut-induced laminitis. Equine Vet J. 2004;36:285–291. MEDLINE | CrossRef

23. 23Belknap JK, Giguère S, Pettigrew A, Cochran AM, Van Eps AW, Pollitt CC. Lamellar pro-inflammatory cytokine expression patterns in laminitis at the developmental stage and at the onset of lameness: innate vs. adaptive immune response. Equine Vet J. 2007;39:42–47. MEDLINE | CrossRef

24. 24Loftus JP, Belknap JK, Stankiewicz KM, Black SJ. Laminar xanthine oxidase, superoxide dismutase and catalase activities in the prodromal stage of black-walnut induced equine laminitis. Equine Vet J. 2007;39:48–53. MEDLINE | CrossRef

25. 25Noschka E, Vandenplas ML, Hurley DJ, Moore JN. Temporal aspects of laminar gene expression during the developmental stages of equine laminitis. Vet Immunol Immunopath. 2009;129:242–253.

26. 26Blikslager AT, Yin C, Cochran AM, Wooten JG, Pettigrew A, Belknap JK. Cyclooxygenase expression in the early stages of equine laminitis: a cytologic study. J Vet Intern Med. 2006;20:1191–1196. MEDLINE | CrossRef

27. 27Yin C, Pettigrew A, Loftus JP, Black SJ, Belknap JK. Tissue concentrations of 4-HNE in the black walnut extract model of laminitis: indication of oxidant stress in affected laminae. Vet Immunol Immunopath. 2009;129:211–215.

28. 28Carter RA, Treiber KH, Geor RJ, Douglass L, Harriss PJ. Prediction of incipient pasture associated laminitis from hyperinsulinaemia, hyperleptinaemia, and generalized obesity in a cohort of ponies. Equine Vet J. 2009;41:171–178. CrossRef

29. 29Bailey SR, Habershon-Butcher JL, Ransom KJ, Elliott J, Menzies-Gow MJ. Hypertension and insulin resistance in a mixed breed population of ponies predisposed to laminitis. Am J Vet Res. 2008;69:122–129. CrossRef

30. 30Treiber K, Carter R, Gay L, Williams C, Geor R. Inflammatory and redox status of ponies with a history of pasture-associated laminitis. Vet Immunol Immunopath. 2009;129:216–220.

31. 31Robertson TP, Bailey SR, Peroni JF. Equine laminitis: a journey to the dark side of venous. Vet Immuno Immunopath. 2009;129:164–166.

32. 32Allen D, Clark ES, Moore JN, Prasse KW. Evaluation of equine digital Starling forces and hemodynamics during early laminitis. Am J Vet Res. 1990;51:1930–1934. MEDLINE

33. 33Eaton SA, Allen D, Eades SC, Schneider DA. Digital Starling forces and hemodynamics during early laminitis induced by an aqueous extract of black walnut (Juglans nigra) in horses. Am J Vet Res. 1995;56:1338–1344. MEDLINE

34. 34Eades SC, Stokes AM, Moore RM. Effects of an endothelin receptor antagonist and nitroglycerin on digital vascular function in horses during the prodromal stages of carbohydrate overload-induced laminitis. Am J Vet Res. 2006;67:1204–1211. MEDLINE | CrossRef

35. 35Keen JA, Hillier C, McGorum BC, Nally JE. Endothelin mediated contraction of equine laminar veins. Equine Vet J. 2008;40:488–492. CrossRef

36. 36Bailey SR, Marr CM, Elliott J. Identification and quantification of amines in the equine caecum. Res Vet Sci. 2003;74:113–118. MEDLINE | CrossRef

37. 37Geor R, Frank N. Metabolic syndrome—from human organ disease to laminar failure in equids. Vet Immunol Immunopath. 2009;129:151–154.

Equine Health Studies Program, Department of Veterinary Clinical Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA

PII: S0737-0806(10)00049-3

doi:10.1016/j.jevs.2010.01.047


View previous. 7 of 49 View next.